|
65677356212eaade2e0e1264
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009858C
|
76_42198
|
1
|
Ethiopia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.5
|
0.024334
|
0
|
0
|
0.5
|
0.024334
|
0
|
0.5
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677356212eaade2e0e1265
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009858B
|
76_42198
|
3
|
Ethiopia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.3
|
0
|
0
|
0
|
0.3
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677356212eaade2e0e1266
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009858E
|
76_42198
|
3
|
Ethiopia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.099803
|
0
|
0
|
0
|
0.099803
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677356212eaade2e0e1267
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009858D
|
76_42198
|
3
|
Ethiopia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.454971
|
0
|
0
|
0
|
0.454971
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677356212eaade2e0e1268
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009858A
|
76_42198
|
3
|
Ethiopia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.081691
|
0
|
0
|
0
|
0.081691
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677356212eaade2e0e1269
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009858G
|
76_42198
|
3
|
Ethiopia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.000531
|
0
|
0
|
0
|
0.000531
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13040
|
STD control including HIV/AIDS
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677357212eaade2e0e126a
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019022088
|
76_60661
|
3
|
Ethiopia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
1.55097
|
0
|
0
|
0
|
1.55097
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
0
|
|
|
65677357212eaade2e0e126b
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009860A
|
76_42198
|
3
|
Ghana
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.15
|
0
|
0
|
0
|
0.15
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677357212eaade2e0e126c
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009860C
|
76_42198
|
3
|
Ghana
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.047394
|
0
|
0
|
0
|
0.047394
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677357212eaade2e0e126d
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009860B
|
76_42198
|
3
|
Ghana
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.05
|
0
|
0
|
0
|
0.05
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677357212eaade2e0e126e
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009861A
|
76_42198
|
3
|
Guinea
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.163381
|
0
|
0
|
0
|
0.163381
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677357212eaade2e0e126f
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009861B
|
76_42198
|
3
|
Guinea
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.2
|
0
|
0
|
0
|
0.2
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677357212eaade2e0e1270
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009862A
|
76_42198
|
1
|
Indonesia
|
Far East Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.25
|
0.851556
|
0
|
0
|
0.25
|
0.851556
|
0
|
0.25
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677357212eaade2e0e1271
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009862B
|
76_42198
|
1
|
Indonesia
|
Far East Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.65
|
0.65
|
0
|
0
|
0.65
|
0.65
|
0
|
0.65
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13040
|
STD control including HIV/AIDS
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677357212eaade2e0e1272
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019022090
|
76_60661
|
1
|
Jordan
|
Middle East
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.048397
|
0.042556
|
0
|
0
|
0.048397
|
0.042556
|
0
|
|
|
0.048397
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
0
|
|
|
65677357212eaade2e0e1273
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009863
|
76_42198
|
3
|
Kenya
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.059449
|
0
|
0
|
0
|
0.059449
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
65677358212eaade2e0e1274
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019022091
|
76_60661
|
3
|
Kenya
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
1.24408
|
0
|
0
|
0
|
1.24408
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
65677358212eaade2e0e1275
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019024003B
|
76_62926
|
1
|
Kenya
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.2
|
0
|
0
|
0
|
0.2
|
0
|
0
|
|
|
0.2
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened; the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities; medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors; limited health resources must be generated, invested, and used efficiently; and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
65677358212eaade2e0e1276
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019024003A
|
76_62926
|
1
|
Kenya
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.2
|
0
|
0
|
0
|
0.2
|
0
|
0
|
|
|
0.2
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened; the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities; medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors; limited health resources must be generated, invested, and used efficiently; and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
65677358212eaade2e0e1277
|
2019
|
United States
|
State Department
|
2019006376
|
65_11186
|
3
|
Lebanon
|
Middle East
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0
|
0.364425
|
0
|
0
|
0
|
0.364425
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
ENSURING ACCESS TO CHRONIC MED...ICATIONS FOR SYRIAN REFUGEES AND VULNERABLE HOST COMMUNITIES IN LEBANON
more
|
Ensuring Access to Chronic Med...ications for Syrian Refugees and Vulnerable Host Communities in Lebanon
more
|
United States Population Migra...tion and Refugee Assistance, Appropriation 1143. Protection and assistance needs of refugees, migrants and conflict vicitms worldwide. [World Health Organisation]
more
|
|
72010
|
Material relief assistance and... services
more
|
|
VIII.1. Emergency Response
|
41307
|
World Health Organisation - as...sessed contributions
more
|
World Health Organisation - as...sessed contributions
more
|
|
|
|
65677358212eaade2e0e1278
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009864A
|
76_42198
|
3
|
Liberia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.3
|
0
|
0
|
0
|
0.3
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
65677358212eaade2e0e1279
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009864B
|
76_42198
|
3
|
Liberia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.146404
|
0
|
0
|
0
|
0.146404
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
65677358212eaade2e0e127a
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019024004
|
76_62926
|
1
|
Liberia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.2
|
0
|
0
|
0
|
0.2
|
0
|
0
|
|
|
0.2
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened; the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities; medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors; limited health resources must be generated, invested, and used efficiently; and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
65677358212eaade2e0e127b
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009865
|
76_42198
|
3
|
Mali
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.359434
|
0
|
0
|
0
|
0.359434
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
65677358212eaade2e0e127c
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019022092
|
76_60661
|
3
|
Mali
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.872014
|
0
|
0
|
0
|
0.872014
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
65677358212eaade2e0e127d
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009866C
|
76_42198
|
3
|
Mozambique
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.1
|
0
|
0
|
0
|
0.1
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
65677359212eaade2e0e127e
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009866B
|
76_42198
|
3
|
Mozambique
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.257971
|
0
|
0
|
0
|
0.257971
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
65677359212eaade2e0e127f
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009866D
|
76_42198
|
3
|
Mozambique
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.030634
|
0
|
0
|
0
|
0.030634
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
65677359212eaade2e0e1280
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009866A
|
76_42198
|
3
|
Mozambique
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.3
|
0
|
0
|
0
|
0.3
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
65677359212eaade2e0e1281
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019022093D
|
76_60661
|
1
|
Mozambique
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.5
|
0.301091
|
0
|
0
|
0.5
|
0.301091
|
0
|
|
|
0.5
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
|
12110
|
Health policy and administrati...ve management
more
|
|
I.2.a. Health, General
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
65677359212eaade2e0e1282
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009856A
|
76_42198
|
3
|
Myanmar
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.11656
|
0
|
0
|
0
|
0.11656
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
65677359212eaade2e0e1283
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009856B
|
76_42198
|
1
|
Myanmar
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0.031316
|
0
|
0
|
0
|
0.031316
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
65677359212eaade2e0e1284
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019024002
|
76_62926
|
1
|
Myanmar
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.3
|
0
|
0
|
0
|
0.3
|
0
|
0
|
|
|
0.3
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened; the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities; medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors; limited health resources must be generated, invested, and used efficiently; and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
65677359212eaade2e0e1285
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019024005B
|
76_62926
|
1
|
Nepal
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.525
|
0
|
0
|
0
|
0.525
|
0
|
0
|
|
|
0.525
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened; the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities; medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors; limited health resources must be generated, invested, and used efficiently; and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
65677359212eaade2e0e1286
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019024005A
|
76_62926
|
1
|
Nepal
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.475
|
0
|
0
|
0
|
0.475
|
0
|
0
|
|
|
0.475
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened; the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities; medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors; limited health resources must be generated, invested, and used efficiently; and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
65677359212eaade2e0e1287
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009867B
|
76_42198
|
1
|
Nigeria
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0.115
|
0
|
0
|
0
|
0.115
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677359212eaade2e0e1288
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009867A
|
76_42198
|
1
|
Nigeria
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.2
|
0
|
0
|
0
|
0.2
|
0
|
0
|
0.2
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
6567735a212eaade2e0e1289
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009868A
|
76_42198
|
3
|
Pakistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.693224
|
0
|
0
|
0
|
0.693224
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
6567735a212eaade2e0e128a
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009868B
|
76_42198
|
1
|
Pakistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0.034
|
0
|
0
|
0
|
0.034
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
6567735a212eaade2e0e128b
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009869A
|
76_42198
|
3
|
Senegal
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.122536
|
0
|
0
|
0
|
0.122536
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
6567735a212eaade2e0e128c
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009869B
|
76_42198
|
3
|
Senegal
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.065752
|
0
|
0
|
0
|
0.065752
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
6567735a212eaade2e0e128d
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019022097
|
76_60661
|
3
|
Senegal
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.876829
|
0
|
0
|
0
|
0.876829
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
6567735a212eaade2e0e128e
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019024006
|
76_62926
|
1
|
Senegal
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.28
|
0
|
0
|
0
|
0.28
|
0
|
0
|
|
|
0.28
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened; the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities; medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors; limited health resources must be generated, invested, and used efficiently; and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
6567735a212eaade2e0e128f
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019022098
|
76_60661
|
3
|
Sierra Leone
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.671168
|
0
|
0
|
0
|
0.671168
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
6567735a212eaade2e0e1290
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009874A
|
76_42198
|
3
|
South of Sahara, regional
|
South of Sahara
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.104588
|
0
|
0
|
0
|
0.104588
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
6567735a212eaade2e0e1291
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009874B
|
76_42198
|
3
|
South of Sahara, regional
|
South of Sahara
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.122382
|
0
|
0
|
0
|
0.122382
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13040
|
STD control including HIV/AIDS
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
|
|
|
6567735a212eaade2e0e1292
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019022104
|
76_60661
|
3
|
South of Sahara, regional
|
South of Sahara
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.82594
|
0
|
0
|
0
|
0.82594
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
6567735b212eaade2e0e1293
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019022100
|
76_60661
|
3
|
Tanzania
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
1.70812
|
0
|
0
|
0
|
1.70812
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
6567735b212eaade2e0e1294
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009885A
|
76_42276
|
1
|
Uganda
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-0.045703
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
SECURING UGANDAN'S RIGHT TO ES...SENTIAL MEDICINES (SURE)
more
|
Securing Ugandan's Right to Es...sential Medicines (SURE)
more
|
Securing Ugandans' Right for E...ssential Medicines (Uganda SURE) aims to aims to assist the Government of Ugandas commitment to strengthen the national pharmaceutical supply system to ensure that the people of Uganda have access to adequate quantities of good quality essential medicines and health supplies. To achieve this goal, SURE's objectives are to: 1) Improve Uganda's policy, legal, and regulatory framework to produce pharmaceutical supply chain stability and sustainability; 2) Improve capacity and performance of central government entities to carry out their supply chain management responsibilities; 3) Improve capacity and performance of districts, health subdistricts, and implementing partners in their supply chain management roles. SURE works on integrating Uganda's supply chain and establishing a pharmaceutical management information system that provides full transparency to minimize medicine stock-outs and waste.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
6567735b212eaade2e0e1295
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009885B
|
76_42276
|
1
|
Uganda
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-0.024448
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
SECURING UGANDAN'S RIGHT TO ES...SENTIAL MEDICINES (SURE)
more
|
Securing Ugandan's Right to Es...sential Medicines (SURE)
more
|
Securing Ugandans' Right for E...ssential Medicines (Uganda SURE) aims to aims to assist the Government of Ugandas commitment to strengthen the national pharmaceutical supply system to ensure that the people of Uganda have access to adequate quantities of good quality essential medicines and health supplies. To achieve this goal, SURE's objectives are to: 1) Improve Uganda's policy, legal, and regulatory framework to produce pharmaceutical supply chain stability and sustainability; 2) Improve capacity and performance of central government entities to carry out their supply chain management responsibilities; 3) Improve capacity and performance of districts, health subdistricts, and implementing partners in their supply chain management roles. SURE works on integrating Uganda's supply chain and establishing a pharmaceutical management information system that provides full transparency to minimize medicine stock-outs and waste.
more
|
|
13040
|
STD control including HIV/AIDS
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
